🔎 Trials Near Me

Home › Type 2 Diabetes › Indiana › Evansville

Type 2 Diabetes clinical trials in Evansville, IN

6 studies for Type 2 Diabetes are looking for participants at sites in and around Evansville (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

RecruitingPhase 3
  • Research Integrity, LLC, Owensboro · 28 mi away
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07064473

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

RecruitingPhase 3
  • MediSphere Medical Research Center, LLC, Evansville
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07595549

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

RecruitingPhase 3
  • AURORA-2 Clinical Site, Evansville
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

RecruitingPhase 2
  • AES - DRS - Synexus Clinical Research US, Inc. - Evansville, Evansville
Ages 18 to 75 · All sexes · Updated Sep 15, 2026 · NCT07340320

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

RecruitingPhase 3
  • Research Site, Evansville
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT07662109

About Type 2 Diabetes

Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.

More about Type 2 Diabetes on MedlinePlus

Type 2 Diabetes trials in other cities

Other studies in Evansville

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.